1. Home
  2. CNMD vs PHAR Comparison

CNMD vs PHAR Comparison

Compare CNMD & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CONMED Corporation

CNMD

CONMED Corporation

HOLD

Current Price

$49.72

Market Cap

985.5M

Sector

Health Care

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$11.07

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNMD
PHAR
Founded
1970
1988
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
985.5M
1.0B
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
CNMD
PHAR
Price
$49.72
$11.07
Analyst Decision
Hold
Strong Buy
Analyst Count
5
3
Target Price
$46.25
$38.33
AVG Volume (30 Days)
734.0K
7.7K
Earning Date
04-29-2026
05-07-2026
Dividend Yield
1.11%
N/A
EPS Growth
N/A
N/A
EPS
1.22
N/A
Revenue
$1,374,724,000.00
N/A
Revenue This Year
$0.82
$10.04
Revenue Next Year
$5.48
$2.51
P/E Ratio
$40.26
$3,041.22
Revenue Growth
5.18
N/A
52 Week Low
$31.44
$9.62
52 Week High
$56.64
$21.34

Technical Indicators

Market Signals
Indicator
CNMD
PHAR
Relative Strength Index (RSI) 64.63 35.79
Support Level $40.14 $9.62
Resistance Level $53.66 $17.89
Average True Range (ATR) 2.10 0.48
MACD 0.25 -0.12
Stochastic Oscillator 63.63 31.75

Price Performance

Historical Comparison
CNMD
PHAR

About CNMD CONMED Corporation

Conmed Corp is a medical technology company that provides devices and equipment for surgical procedures. The company's products are used by surgeons and other healthcare professionals across specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Geographically, the company operates in the United States, Europe, the Middle East & Africa, Asia Pacific, and the Americas, excluding the United States. The majority of revenue is generated from the United States.

About PHAR Pharming Group N.V.

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.

Share on Social Networks: